Tris Pharma INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$5.5Mgeneral payments (2019-2025)
$687Kresearch payments (2019-2025)
24,859clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $856K
2020 $251K
2021 $386K
2022 $576K
2023 $926K
2024 $743K
2025 $1.7M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Psychiatry $2.1M
Pediatrics $824K
Child & Adolescent Psychiatry $736K
Psychiatric/Mental Health (Nurse Practitioner) $376K
Family $174K
Physician Assistant $144K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Joel Young Rochester Hills, MI Psychiatry $576,718.00
Ann Childress Las Vegas, NV Child & Adolescent Psychiatry $528,919.26
Michael Feld Northbrook, IL Psychiatry $326,583.19
Alice Mao Houston, TX Psychiatry $128,786.01
Maurice Ohayon Stanford, CA Psychiatry $90,073.56
Suvrat Bhargave Tyrone, GA $76,610.55
Cathal Grant Bedford, TX Psychiatry $53,171.29
Victor Abdow Rockville, MD Pediatrics $50,552.71
Mark Wright Lexington, KY Psychiatry $49,605.53
Jeffrey Gudin Miami, FL Pain Medicine (Anesthesiology) $48,654.76

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.